Interleukin 2 receptor antagonists for kidney transplant recipients

BACKGROUND: Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but the proportion of new transplant recipients receiving IL2Ra differs around t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cochrane Database Syst Rev
Egile Nagusiak: Webster, Angela C, Ruster, Lorenn P, McGee, Richard G, Matheson, Sandra L, Higgins, Gail Y, Willis, Narelle S, Chapman, Jeremy R, Craig, Jonathan C
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Ltd 2010
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7154335/
https://ncbi.nlm.nih.gov/pubmed/20091551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003897.pub3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak